Detecting Malingering Detection Using Eye Movements and Response Time (MDER)
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
Performance Validity Tests (PVTs) are widely used for the detection of sub-optimal effort and malingering in neuropsychological assessments. Threats to their validity however likely to intensify with time (e.g., information available on the web or from legal representatives) and may lead to a decline in their ability to differentiate between malingerers and non-malingerers. Eye movements and response time (RT) are less obvious outcome measures and under less conscious control than more conventional PVT indices (e.g., accuracy). They are therefore promising measures that can aid in detecting malingering when used in conjunction with more conventional PVT indices. The Word Memory Test (WMT) is a widely used PVT in neuropsychological evaluations. As part of the proposed study, TBI patients, chronic pain patients and healthy adults (60 in each group) will be randomly divided to one of two conditions; optimal effort or sub-optimal effort (participants will be asked to play a TBI patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits). The proposed study will improve the WMT's efficacy in detection of sub-optimal effort in neuropsychological evaluations and therefore protect its validity from future threats. In addition, the proposed study will provide us with better understanding of the effect of TBI on eye movements and RTs in general.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2017
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2017
CompletedFirst Posted
Study publicly available on registry
June 28, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedJune 28, 2017
January 1, 2017
1.5 years
January 17, 2017
June 26, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Eye Movements
Eye tracking used to evaluate eye behavior.
1 month
Study Arms (4)
Sub-optimal Traumatic Brain Injury
EXPERIMENTALSub-optimal effort
Sub-optimal effort Chronic pain
EXPERIMENTALSub-optimal effort
Traumatic Brain Injury
NO INTERVENTIONoptimal effort
Chronic pain
NO INTERVENTIONoptimal effort
Interventions
Participants will be asked to play a patient who wishes to present himself as having cognitive deficits or exaggerate existing cognitive deficits
Participants will be asked to perform tasks to the best of their abilities.
Eligibility Criteria
You may qualify if:
- Adult (18-65) female and males.
- Signed informed consent form.
- TBI of at least mild severity, as operationalized by Post traumatic amnesia (PTA) \< 24 hours
- Glasgow coma scale (GCS) of 13-15
- Loss of consciousness (LOC) of 30 minutes or less.
- Pain without apparent biological value that has persisted beyond three months. This will be based on the participant self-report, electronic medical records and consultation with treating physician.
You may not qualify if:
- Any current eye impairment (e.g., limited visual field, nystagmus, astigmatism \[cylinder\], strabismus or any other impairment specified by the participant), past strabismus, and refractive surgery.
- Significant past neurological disorder/s and/or neurosurgery (special emphasis will be put on any language impairment such as aphasia).
- Significant developmental disorders (e.g., learning disabilities such as dyslexia). (d)
- Significant past or present psychiatric disorders (as evident, for example, in psychiatric inpatient hospitalization and past suicide attempts).
- Significant current neurological disorder/s (special emphasis will be put on any language impairment such as aphasia) as decided by a joint consultation of the research team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Loewenstein Hospitallead
- Ariel Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moti Ratmansky, MD
Loewenstein Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2017
First Posted
June 28, 2017
Study Start
July 1, 2017
Primary Completion
January 1, 2019
Study Completion
January 1, 2019
Last Updated
June 28, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share IPD